NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 26 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $33,000 | -72.3% | 33,467 | -50.6% | 0.00% | – |
| Q3 2021 | $119,000 | -37.0% | 67,779 | -34.4% | 0.00% | – |
| Q2 2021 | $189,000 | -35.3% | 103,321 | -28.6% | 0.00% | -100.0% |
| Q1 2021 | $292,000 | +33.3% | 144,645 | +41.9% | 0.00% | 0.0% |
| Q4 2020 | $219,000 | +24.4% | 101,949 | +56.6% | 0.00% | 0.0% |
| Q3 2020 | $176,000 | -48.8% | 65,089 | -25.5% | 0.00% | -50.0% |
| Q2 2020 | $344,000 | – | 87,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 52,926 | $113,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 109,940 | $236,000 | 0.01% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $22,000 | 0.00% |
| Sowell Financial Services LLC | 11,190 | $24,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 101,949 | $219,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 32,822 | $71,000 | 0.00% |
| UBS Group AG | 816 | $2,000 | 0.00% |
| IFP Advisors, Inc | 50 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 6 | $0 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $2,000 | 0.00% |